| Organism name | Flindersia laevicarpa C.T.White et Francis. | 
|---|---|
| Genus | Flindersia | 
| Family | Rutaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Flindersia | 
|---|---|
| Linked NCBI taxonomy ID | 43712 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Rutaceae | 
|---|---|
| ID | 23513 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | rosids | 
|---|---|
| ID | 71275 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00003749   | Lupeol / Lupenol / (+)-Lupenol | CHEMBL289191 CHEMBL459702 | C010480 | 3 / 0 / 0 | 2 / 6 | No. 23 | No. 51 |   | 
| C00013432   | Carpachromene / 5,4'-Dihidroxy-6'',6''-dimethylpyrano[2'',3'':7,6]flavone / 5-Hydroxy-8-(4-hydroxyphenyl)-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one | No. 24 | No. 15 |   | ||||
| C00000970   | Hesperidin | CHEMBL265606 CHEMBL449317 CHEMBL1314714 CHEMBL1328143 CHEMBL1535112 CHEMBL1574000 CHEMBL2140112 | D006569 | 24 / 9 / 14 | 10 / 5 | No. 48 | No. 14 |   | 
| C00003672   | Sitosterol / beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol | CHEMBL221542 CHEMBL1398443 CHEMBL1875388 | 17 / 19 / 12 | No. 53 | No. 11 |   | ||
| C00002198   | Skimmianine | CHEMBL21396 | C035932 | 18 / 32 / 62 | No. 368 | No. 7 |   | |
| C00000206   | Saligel / Salonil / Salicylic acid / 2-Carboxyphenol / o-Hydroxybenzoic acid | CHEMBL424 | D020156 | 124 / 50 / 42 | 15 / 12 | No. 817 | No. 81 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000206 C00000970 C00002198 C00003672 | 1 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000206 C00000970 C00002198 C00003672 | 0 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000206 C00000970 C00002198 C00003672 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000206 C00000970 C00002198 C00003672 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000206 C00000970 C00002198 C00003672 | 0 / 1 | 
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000206 C00002198 | 2 / 2 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000970 C00003672 | 1 / 1 | 
| O00255 | Menin | Unclassified protein | C00000970 C00002198 | 2 / 5 | 
| P03372 | Estrogen receptor | NR3A1 | C00000206 C00003672 | 1 / 1 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000206 C00002198 | 0 / 0 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000970 C00002198 | 1 / 2 | 
| O75496 | Geminin | Unclassified protein | C00000206 C00002198 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000206 C00002198 | 0 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000206 C00002198 | 0 / 0 | 
| P06746 | DNA polymerase beta | Enzyme | C00000970 C00003672 | 0 / 0 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000206 C00003672 | 0 / 0 | 
| P08183 | Multidrug resistance protein 1 | drug | C00000206 C00003672 | 1 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00002198 C00003672 | 3 / 2 | 
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 C00003749 | 0 / 0 | 
| P36537 | UDP-glucuronosyltransferase 2B10 | Enzyme | C00000206 | 0 / 0 | 
| P29466 | Caspase-1 | C14 | C00000206 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00000206 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000206 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00000206 | 2 / 2 | 
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00000970 | 0 / 0 | 
| P62158 | Calmodulin | Unclassified protein | C00000970 | 1 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00002198 | 11 / 10 | 
| P43166 | Carbonic anhydrase 7 | Lyase | C00000206 | 0 / 0 | 
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000206 | 0 / 0 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00000206 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000206 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00000206 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00000206 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000206 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000206 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 | 
| P02768 | Serum albumin | Secreted protein | C00000206 | 0 / 0 | 
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000206 | 0 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000206 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000206 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000206 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000206 | 0 / 0 | 
| P08236 | Beta-glucuronidase | Enzyme | C00000206 | 1 / 2 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002198 | 1 / 0 | 
| Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00000970 | 0 / 0 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000206 | 1 / 8 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00003749 | 0 / 0 | 
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003749 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000206 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000206 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000206 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000206 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000206 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000206 | 0 / 0 | 
| P23280 | Carbonic anhydrase 6 | Lyase | C00000206 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000206 | 0 / 0 | 
| P05067 | Amyloid beta A4 protein | Membrane receptor | C00000206 | 2 / 2 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000206 | 1 / 1 | 
| O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | C00000206 | 0 / 0 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000206 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000206 | 1 / 0 | 
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000206 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000206 | 0 / 0 | 
| O43570 | Carbonic anhydrase 12 | Lyase | C00000206 | 1 / 2 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000206 | 0 / 0 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000206 | 0 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00000206 | 2 / 1 | 
| Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00000206 | 0 / 0 | 
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000206 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000206 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000206 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000206 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000206 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000206 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00000206 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000206 | 0 / 0 | 
| P15121 | Aldose reductase | Enzyme | C00000206 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000206 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000206 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000206 | 1 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00000206 | 0 / 0 | 
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000206 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00000206 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000206 | 1 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00000206 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000206 | 0 / 0 | 
| Q9Y253 | DNA polymerase eta | Enzyme | C00000970 | 1 / 1 | 
| P11308 | Transcriptional regulator ERG | Unclassified protein | C00000970 | 1 / 2 | 
| Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00000206 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000970 | 0 / 0 | 
| P00734 | Prothrombin | S1A | C00003672 | 4 / 2 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00000206 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000206 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000206 | 0 / 0 | 
| P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000206 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000206 | 2 / 0 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000206 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000206 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00000206 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000206 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000206 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000206 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000206 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000206 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000206 | 2 / 1 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000206 | 2 / 2 | 
| Q16790 | Carbonic anhydrase 9 | Lyase | C00000206 | 0 / 1 | 
| P08253 | 72 kDa type IV collagenase | M10A | C00000206 | 1 / 3 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002198 | 3 / 3 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000206 | 0 / 3 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002198 | 0 / 0 | 
| P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00000206 | 0 / 0 | 
| P22894 | Neutrophil collagenase | M10A | C00000206 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000206 | 0 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000206 | 0 / 0 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000206 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00000206 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000206 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000206 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000206 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000206 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00000206 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000206 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000206 | 0 / 0 | 
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00000206 | 0 / 0 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000206 | 0 / 0 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000970 | 0 / 0 | 
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00000970 | 0 / 0 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000970 | 0 / 0 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000206 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000206 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000206 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000206 | 1 / 1 | 
| P07451 | Carbonic anhydrase 3 | Lyase | C00000206 | 0 / 0 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00000206 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000206 | 0 / 0 | 
| P08254 | Stromelysin-1 | M10A | C00000206 | 1 / 0 | 
| Q9Y251 | Heparanase | Enzyme | C00000970 | 0 / 0 | 
| P22748 | Carbonic anhydrase 4 | Lyase | C00000206 | 1 / 1 | 
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00000970 | 0 / 0 | 
| Q9UHC3 | Acid-sensing ion channel 3 | Unclassified protein | C00000206 | 0 / 0 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000206 | 0 / 0 | 
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000970 | 0 / 0 | 
| Q16637 | Survival motor neuron protein | Unclassified protein | C00000206 | 4 / 1 | 
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002198 | 7 / 37 | 
| Q02410 | Amyloid beta A4 precursor protein-binding family A member 1 | Unclassified protein | C00000970 | 0 / 0 | 
| Q00975 | Voltage-dependent N-type calcium channel subunit alpha-1B | N-TYPE | C00000970 | 0 / 0 | 
| Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00000206 | 0 / 0 | 
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00000970 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa | C00003749 | 
| 5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) | C00003749 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00000970 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00000970 | 
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) | C00000970 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00000970 | 
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) | C00000970 | 
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) | C00000970 | 
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | C00000970 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00000970 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00000970 | 
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 | C00000970 | 
| 1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) | C00000206 | 
| 1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) | C00000206 | 
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | C00000206 | 
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 | C00000206 | 
| 23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F | C00000206 | 
| 4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A | C00000206 | 
| 55867 | SLC22A11, OAT4, hOAT4 | solute carrier family 22 (organic anion/urate transporter), member 11 | C00000206 | 
| 9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 | C00000206 | 
| 10864 | SLC22A7, NLT, OAT2 | solute carrier family 22 (organic anion transporter), member 7 | C00000206 | 
| 114571 | SLC22A9, HOAT4, OAT4, OAT7, UST3H, ust3 | solute carrier family 22 (organic anion transporter), member 9 | C00000206 | 
| 7295 | TXN, TRDX, TRX, TRX1 | thioredoxin | C00000206 | 
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | C00000206 | 
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | C00000206 | 
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | C00000206 | 
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | C00000206 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #202300 | Adrenocortical carcinoma, hereditary; adcc | P04637 | 
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #104300 | Alzheimer disease; ad | P05067 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #218030 | Apparent mineralocorticoid excess; ame | P80365 | 
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 | P04637 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #605714 | Cerebral amyloid angiopathy, app-related | P05067 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 | P08254 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #119900 | Digital clubbing, isolated congenital | P15428 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #133239 | Esophageal cancer | P04637 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #612219 | Ewing sarcoma; es | P11308 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #143860 | Hyperchlorhidrosis, isolated | O43570 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 | P15428 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #151623 | Li-fraumeni syndrome 1; lfs1 | P04637 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 P04637 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #253220 | Mucopolysaccharidosis, type vii; mps7 | P08236 | 
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona | P08253 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260500 | Papilloma of choroid plexus; cpp | P04637 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 | P00734 | 
| #613679 | Prothrombin deficiency, congenital | P00734 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #600852 | Retinitis pigmentosa 17; rp17 | P22748 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #253300 | Spinal muscular atrophy, type i; sma1 | Q16637 | 
| #253550 | Spinal muscular atrophy, type ii; sma2 | Q16637 | 
| #253400 | Spinal muscular atrophy, type iii; sma3 | Q16637 | 
| #271150 | Spinal muscular atrophy, type iv; sma4 | Q16637 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #275355 | Squamous cell carcinoma, head and neck; hnscc | P04637 | 
| #601367 | Stroke, ischemic | P00734 | 
| #188050 | Thrombophilia due to thrombin defect; thph1 | P00734 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #614916 | Ventricular tachycardia, catecholaminergic polymorphic, 4; cpvt4 | P62158 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #278750 | Xeroderma pigmentosum, variant type; xpv | Q9Y253 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) P04637 (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H01302 | Hyperchlorhidrosis isolated (HCHLH) | O43570
                            (related) | 
| H00021 | Renal cell carcinoma | O43570
                            (marker) P04637 (marker) Q16790 (marker) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P04637 (related) P04637 (marker) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) P04637 (related) P08253 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00223 | Inherited thrombophilia | P00734
                            (related) | 
| H01254 | Congenital prothrombin deficiency | P00734
                            (related) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) P04637 (related) Q92731 (marker) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) P04637 (related) P04637 (marker) | 
| H00027 | Ovarian cancer | P04626
                            (related) P04637 (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) P04637 (related) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P04637 (related) P35354 (related) | 
| H00004 | Chronic myeloid leukemia (CML) | P04637
                            (related) | 
| H00005 | Chronic lymphocytic leukemia (CLL) | P04637
                            (related) | 
| H00006 | Hairy-cell leukemia | P04637
                            (related) | 
| H00008 | Burkitt lymphoma | P04637
                            (related) | 
| H00009 | Adult T-cell leukemia | P04637
                            (related) | 
| H00010 | Multiple myeloma | P04637
                            (related) | 
| H00013 | Small cell lung cancer | P04637
                            (related) | 
| H00014 | Non-small cell lung cancer | P04637
                            (related) | 
| H00015 | Malignant pleural mesothelioma | P04637
                            (related) | 
| H00020 | Colorectal cancer | P04637
                            (related) P04637 (marker) | 
| H00025 | Penile cancer | P04637
                            (related) P04637 (marker) P08253 (related) P14780 (related) P35354 (related) | 
| H00029 | Vulvar cancer | P04637
                            (related) | 
| H00032 | Thyroid cancer | P04637
                            (related) | 
| H00036 | Osteosarcoma | P04637
                            (related) P08684 (marker) | 
| H00038 | Malignant melanoma | P04637
                            (related) P14679 (marker) | 
| H00039 | Basal cell carcinoma | P04637
                            (related) | 
| H00040 | Squamous cell carcinoma | P04637
                            (related) | 
| H00041 | Kaposi's sarcoma | P04637
                            (related) | 
| H00044 | Cancer of the anal canal | P04637
                            (related) | 
| H00047 | Gallbladder cancer | P04637
                            (related) | 
| H00048 | Hepatocellular carcinoma | P04637
                            (related) | 
| H00881 | Li-Fraumeni syndrome | P04637
                            (related) | 
| H01007 | Choroid plexus papilloma | P04637
                            (related) | 
| H00056 | Alzheimer's disease (AD) | P05067
                            (related) | 
| H01185 | Cerebral amyloid angiopathy (CAA) | P05067
                            (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00132 | Mucopolysaccharidosis type VII (MPS7) | P08236
                            (related) | 
| H00421 | Mucopolysaccharidosis (MPS) | P08236
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00472 | Torg-Winchester syndrome | P08253
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00024 | Prostate cancer | P11308
                            (related) | 
| H00035 | Ewing's sarcoma | P11308
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00457 | Primary hypertrophic osteoarthropathy (PHO) | P15428
                            (related) | 
| H01246 | Isolated congenital nail clubbing (ICNC) | P15428
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00527 | Retinitis pigmentosa (RP) | P22748
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00259 | Apparent mineralocorticoid excess syndrome | P80365
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q03164
                            (related) Q03164 (marker) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00455 | Spinal muscular atrophy (SMA) | Q16637
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q9NUW8
                            (related) | 
| H00403 | Disorders of nucleotide excision repair | Q9Y253
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D006528 | Carcinoma, Hepatocellular | C00003749 | 
| D009202 | Cardiomyopathies | C00003749 | 
| D006937 | Hypercholesterolemia | C00003749 | 
| D009374 | Neoplasms, Experimental | C00003749 | 
| D012878 | Skin Neoplasms | C00003749 | 
| D014947 | Wounds and Injuries | C00003749 | 
| D058186 | Acute Kidney Injury | C00000970 | 
| D055371 | Acute Lung Injury | C00000970 | 
| D056486 | Drug-Induced Liver Injury | C00000970 | 
| D008171 | Lung Diseases | C00000970 | 
| D012128 | Respiratory Distress Syndrome, Adult | C00000970 | 
| D001249 | Asthma | C00000206 | 
| D003128 | COMA | C00000206 | 
| D004342 | Drug Hypersensitivity | C00000206 | 
| D034381 | Hearing Loss | C00000206 | 
| D006685 | Hoarseness | C00000206 | 
| D007819 | Laryngeal Edema | C00000206 | 
| D009668 | Nose Diseases | C00000206 | 
| D049188 | Prenatal Injuries | C00000206 | 
| D012640 | Seizures | C00000206 | 
| D014012 | Tinnitus | C00000206 | 
| D014581 | Urticaria | C00000206 | 
| D014860 | Warts | C00000206 |